PROPANC BIOPHARMA INC (PPCB) Stock Income Statement
NASDAQ:PPCB • US74346N7012
Current stock price
0.1033 USD
+0 (+1.67%)
At close:
0.1031 USD
0 (-0.19%)
After Hours:
| TTM (2025-9-30) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 61.66M | 57.28M | 1.54M | 1.78M | 1.99M | |||
| Research and Development | 222.20K | 223.70K | 248.10K | 247.90K | 256.10K | |||
| Selling, General, and Administrative Expenses | 61.44M | 57.05M | 1.29M | 1.53M | 1.73M | |||
| Operating Income | -61.66M | -57.28M | -1.54M | -1.78M | -1.99M | |||
| Interest Income/Expense | -1.08M | -774.10K | -468.20K | -1.06M | -704.70K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Non Recurring Items | -663.80K | -871.00K | 54.60K | 43.50K | -17.50K | |||
| Income Before Taxes | -63.41M | -58.92M | -1.95M | -2.79M | -2.71M | |||
| Income Tax | N/A | 0.00 | -129.10K | -129.80K | -55.00K | |||
| Net Income | -63.41M | -58.92M | -2.01M | -3.13M | -2.66M | |||
| EBITDA | N/A | N/A | -1.54M | -1.77M | -1.99M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -45.47 | -14.85 | -1.42K | -104.23K | -1.95M | |||
| Statistics | ||||||||
All data in USD